Back to search
Pediatric Recurrent Central Nervous System Tumors
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Pediatric Recurrent Central Nervous System Tumors trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Pediatric Recurrent Central Nervous System Tumors trials you may qualify forThe purpose of this research study is to learn about the safety and feasibility of giving a personalized DNA vaccine to people with central nervous system tumor…
The purpose of this study is to find out whether selinexor is an effective treatment for people who have a relapsed/refractory Wilms tumor, rhabdoid tumor, MPNS…
The primary objective will be to demonstrate the manufacturing feasibility and safety, and to determine the maximum tolerated dose (MTD) of RNA-LP vaccines in (…
This is a Phase 1 study of central nervous system (CNS) locoregional adoptive therapy with autologous CD4+ and CD8+ T cells lentivirally transduced to express a…
This study is a clinical trial to determine the safety of inoculating G207 (an experimental virus therapy) into a recurrent or refractory cerebellar brain tumor…
This study will address the question of whether targeting CMV antigens with PEP-CMV can serve as a novel immunotherapeutic approach in pediatric patients with n…
This study is researching an experimental drug called cemiplimab (called "study drug") and the combination of experimental drugs of fianlimab and cemiplimab (ca…
This phase II Pediatric MATCH screening and multi-sub-trial studies how well treatment that is directed by genetic testing works in pediatric patients with soli…